Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Neurology

Navigating JME for People Who Can Become Pregnant

At a Glance

People with juvenile myoclonic epilepsy can often have healthy pregnancies, but medication and contraception need advance planning. Valproate can harm an unborn baby, estrogen can lower lamotrigine levels, and no antiseizure medicine should be stopped abruptly without neurologist guidance.

Navigating Juvenile Myoclonic Epilepsy (JME) as a person who can become pregnant requires balancing seizure control with long-term reproductive health [1]. Because JME often begins in the teenage years and may require long-term treatment, the choice of medication has significant implications for future family planning and hormone health [2][1].

The Valproate (Depakote) Dilemma

Valproate is often highly effective for JME, but it carries high risks if a person becomes pregnant while taking it [3][4].

  • Birth Defects (Teratogenicity): Pregnancies exposed to valproate have a notably high risk of major birth defects, including heart defects, limb abnormalities, or neural tube issues like spina bifida [4][5]. This risk increases significantly with higher doses [6].
  • Brain Development: Children exposed to valproate in the womb have a higher risk of cognitive delays and autism-spectrum disorders compared to those exposed to other epilepsy drugs [7][8].
  • Current Guidelines: Because of these risks, guidelines recommend avoiding valproate in people who can become pregnant whenever possible [1][9]. In some jurisdictions, pregnancy-prevention programs are in place for anyone prescribed this drug [10]. If valproate is the most effective drug for your seizure type, it must be used with preconception counseling, reliable contraception, and shared decision-making [10][1].

Birth Control and Medication Interactions

If you use hormonal birth control, it can interfere with how your body processes certain epilepsy medications—and vice versa. You must discuss this with both your neurologist and your gynecologist.

  • The Estrogen Interaction: Estrogen (found in most birth control pills, patches, and rings) causes your body to clear lamotrigine much faster than usual [11]. This can drop the amount of medication in your blood by 50% or more, potentially leading to breakthrough seizures during your “active” pill weeks [12][13].
  • The “Off” Week Rebound: During the week you take “placebo” pills, your lamotrigine levels can suddenly spike, leading to side effects like dizziness, double vision, or loss of balance [12][13].
  • Enzyme-Inducing Interactions: Some antiseizure medications can reduce the effectiveness of hormonal methods, including some progestin-only pills and implants, increasing the risk of unintended pregnancy. The interaction is very specific to the drugs involved, so never start or stop a method independently [13][14].

Managing Pregnancy with JME

Most people with JME have healthy pregnancies and healthy babies, but it requires careful coordination with your medical team, including preconception folic acid counseling [15].

  • Balancing Risks: Lamotrigine and levetiracetam are generally considered to have lower fetal risks than valproate, but treatment selection balances fetal safety with the fact that uncontrolled generalized seizures also pose severe risks [16][5].
  • Dose Monitoring: During pregnancy, your body clears medication even faster. Lamotrigine levels can drop significantly starting as early as the first five weeks of pregnancy [17][18]. Doctors must monitor your blood levels frequently and may need to increase your dose [19][20].
  • The Postpartum Plan: After the baby is born, your body returns to its normal metabolism very quickly [19]. If your dose was increased during pregnancy, you must have a patient-specific, written postpartum plan addressing rapid medication dose reduction, sleep deprivation strategies, and breastfeeding safety [21][20].

CRITICAL SAFETY NOTE: If you discover you are pregnant, do not stop your medication abruptly. Stopping your medication can cause a major convulsive seizure, which can lead to life-threatening complications [15][1]. Instead, contact your neurologist immediately to create a safe management plan [22].

Common questions in this guide

Is valproate safe if I may become pregnant?
Valproate can be very effective for JME, but taking it during pregnancy is linked with a higher risk of major birth defects and developmental problems, especially at higher doses. Guidelines recommend avoiding it when possible; if it is needed, discuss reliable contraception, preconception counseling, and alternatives with your neurologist.
Can birth control affect my JME medicine?
Yes. Estrogen-containing pills, patches, and rings can make the body clear lamotrigine faster, which may lower medication levels and contribute to breakthrough seizures. Some antiseizure medicines can also reduce the effectiveness of hormonal birth control, so discuss the specific method and medication combination with your neurologist and gynecologist.
What should I do if I become pregnant while taking JME medicine?
Do not stop your antiseizure medicine abruptly, because an uncontrolled generalized or convulsive seizure can be dangerous. Contact your neurologist promptly so you can make an individualized plan that weighs medication risks against the risks of uncontrolled seizures.
How is lamotrigine monitored during pregnancy?
The body may clear lamotrigine faster very early in pregnancy, causing blood levels to fall. Your medical team may check levels regularly and adjust the dose using your previous stable level, seizure control, and side effects as guides. After delivery, medication levels can change quickly again, so a written postpartum plan is important.
Are lamotrigine and levetiracetam safer than valproate in pregnancy?
Lamotrigine and levetiracetam are generally considered to have lower fetal risks than valproate. No medication choice is risk-free, so treatment decisions balance fetal safety with the serious risks of uncontrolled generalized seizures.
Why do I need a postpartum medication plan?
Medication doses may be increased during pregnancy, but the body can return to its usual medication processing quickly after delivery. A written plan helps guide safe dose reduction and addresses sleep deprivation and breastfeeding safety.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If I am taking Lamictal (lamotrigine), how will we coordinate blood tests if I start or stop a birth control pill?
  2. 2.Are there specific progestin-only or non-hormonal birth control options you recommend to avoid interfering with my epilepsy medication?
  3. 3.If I am taking Depakote (valproate), what is the step-by-step process for safely transitioning to a pregnancy-safe alternative before I consider starting a family?
  4. 4.How often will you monitor my medication levels during pregnancy, and do we have a 'baseline' level on file for me while I am well?
  5. 5.What is my individualized postpartum plan for reducing my medication dose safely after delivery?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Valproate in the treatment of epilepsy in girls and women of childbearing potential.

    Tomson T, Marson A, Boon P, et al.

    Epilepsia 2015; (56(7)):1006-19 doi:10.1111/epi.13021.

    PMID: 25851171
  2. 2

    Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.

    Serafini A, Gerard E, Genton P, et al.

    CNS drugs 2019; (33(3)):195-208 doi:10.1007/s40263-018-00602-2.

    PMID: 30747367
  3. 3

    Levetiracetam for myoclonic seizures in idiopathic generalized epilepsy: A systematic review and meta-analysis.

    Pereira ARO, Leão IA, Dias LA, Moura RF

    Epilepsy & behavior : E&B 2025; (171()):110512 doi:10.1016/j.yebeh.2025.110512.

    PMID: 40450767
  4. 4

    Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.

    Tomson T, Battino D, Bonizzoni E, et al.

    The Lancet. Neurology 2018; (17(6)):530-538 doi:10.1016/S1474-4422(18)30107-8.

    PMID: 29680205
  5. 5

    Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.

    Weston J, Bromley R, Jackson CF, et al.

    The Cochrane database of systematic reviews 2016; (11()):CD010224 doi:10.1002/14651858.CD010224.pub2.

    PMID: 27819746
  6. 6

    Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.

    Tomson T, Battino D, Bonizzoni E, et al.

    Neurology 2015; (85(10)):866-72 doi:10.1212/WNL.0000000000001772.

    PMID: 26085607
  7. 7

    Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones.

    Daugaard CA, Pedersen L, Sun Y, et al.

    JAMA network open 2020; (3(11)):e2025570 doi:10.1001/jamanetworkopen.2020.25570.

    PMID: 33170264
  8. 8

    Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure.

    Hernández-Díaz S, Straub L, Bateman BT, et al.

    The New England journal of medicine 2024; (390(12)):1069-1079 doi:10.1056/NEJMoa2309359.

    PMID: 38507750
  9. 9

    Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug.

    Tomson T, Battino D, Perucca E

    The Lancet. Neurology 2016; (15(2)):210-218 doi:10.1016/S1474-4422(15)00314-2.

    PMID: 26655849
  10. 10

    The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre.

    Davies P, Reuber M, Grunewald R, et al.

    Seizure 2020; (79()):8-13 doi:10.1016/j.seizure.2020.03.015.

    PMID: 32380376
  11. 11

    Contraceptive vaginal ring reduces lamotrigine levels.

    King A, Bachman E, Macken MP, et al.

    Epilepsy & behavior : E&B 2020; (111()):107162 doi:10.1016/j.yebeh.2020.107162.

    PMID: 32575009
  12. 12

    Bidirectional interaction between oral contraception and lamotrigine in women with epilepsy - Role of progestins.

    Rauchenzauner M, Deichmann S, Pittschieler S, et al.

    Seizure 2020; (74()):89-92 doi:10.1016/j.seizure.2019.11.011.

    PMID: 31869755
  13. 13

    Lamotrigine, Contraceptives, and Psychiatry: A Narrative Review.

    Costa I, Esteves-Sousa D

    Cureus 2025; (17(12)):e100392 doi:10.7759/cureus.100392.

    PMID: 41625825
  14. 14

    Women with epilepsy initiating a progestin IUD: A prospective pilot study of safety and acceptability.

    Davis AR, Saadatmand HJ, Pack A

    Epilepsia 2016; (57(11)):1843-1848 doi:10.1111/epi.13559.

    PMID: 27677612
  15. 15

    Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide.

    Nucera B, Brigo F, Trinka E, Kalss G

    Therapeutic advances in neurological disorders 2022; (15()):17562864221101687 doi:10.1177/17562864221101687.

    PMID: 35706844
  16. 16

    Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability.

    Bjørk MH, Zoega H, Leinonen MK, et al.

    JAMA neurology 2022; (79(7)):672-681 doi:10.1001/jamaneurol.2022.1269.

    PMID: 35639399
  17. 17

    Dosing Optimization of Lamotrigine in Peripregnancy Epilepsy Through PopPK Modelling and Simulation.

    Huo J, Liu Y, Yang J, et al.

    Drug design, development and therapy 2025; (19()):10243-10258 doi:10.2147/DDDT.S541597.

    PMID: 41306944
  18. 18

    Pharmacokinetic changes and therapeutic drug monitoring of lamotrigine during pregnancy.

    Ding Y, Tan X, Zhang S, Guo Y

    Brain and behavior 2019; (9(7)):e01315 doi:10.1002/brb3.1315.

    PMID: 31104352
  19. 19

    Therapeutic Drug Monitoring of Antiepileptic Drugs in Women with Epilepsy Before, During, and After Pregnancy.

    Arfman IJ, Wammes-van der Heijden EA, Ter Horst PGJ, et al.

    Clinical pharmacokinetics 2020; (59(4)):427-445 doi:10.1007/s40262-019-00845-2.

    PMID: 31912315
  20. 20

    Dose Monitoring of Lamotrigine Monotherapy in Pregnancy: Are Pregnant Women with Epilepsy Currently Optimally Managed? A Systematic Review.

    Goo Y, der Nederlanden AM, Bleasel A, et al.

    Therapeutic drug monitoring 2024; (46(2)):181-194 doi:10.1097/FTD.0000000000001186.

    PMID: 38366344
  21. 21

    Dose adjustment of the anti-seizure medications levetiracetam and lamotrigine during the postpartum period. Schedule plan, safety and efficacy.

    Khmelev N, Fahoum F, Goldstein L

    Epilepsy & behavior : E&B 2026; (175()):110858 doi:10.1016/j.yebeh.2025.110858.

    PMID: 41389469
  22. 22

    [Pharmacological treatment of women with epilepsy before and during pregnancy].

    Müffelmann B, Bien CG

    Der Nervenarzt 2016; (87(10)):1115-1126 doi:10.1007/s00115-016-0210-1.

    PMID: 27631817

This page is for informational purposes only and does not constitute medical advice about JME, contraception, or pregnancy. Do not change or stop an antiseizure medicine without speaking with your neurologist.

Get notified when new evidence is published on Juvenile myoclonic epilepsy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.